{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T10:03:58Z","timestamp":1748945038021,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T00:00:00Z","timestamp":1525478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00432-018-2659-8","type":"journal-article","created":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T09:20:58Z","timestamp":1525512058000},"page":"1523-1530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vaginal brachytherapy for endometrial cancer"],"prefix":"10.1007","volume":"144","author":[{"given":"Peter","family":"Hass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selvi","family":"Seinsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holm","family":"Eggemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Ignatov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9006-4029","authenticated-orcid":false,"given":"Atanas","family":"Ignatov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,5]]},"reference":[{"key":"2659_CR1","first-page":"419","volume":"56","author":"J Aalders","year":"1980","unstructured":"Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419\u2013427","journal-title":"Obstet Gynecol"},{"key":"2659_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0360-3016(99)00427-7","volume":"46","author":"JM Anderson","year":"2000","unstructured":"Anderson JM, Stea B, Hallum AV, Rogoff E, Childers J (2000) High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys 46:417\u2013425","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2659_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/IGC.0b013e3182781a6c","volume":"23","author":"MJ Battista","year":"2013","unstructured":"Battista MJ, Steiner E, Rieks N, Steetskamp J, Seeger A, Sicking I et al (2013) Nationwide analysis on surgical staging procedures and systemic treatment for patients with endometrial cancer in Germany. Int J Gynecol Cancer 23:105\u2013112","journal-title":"Int J Gynecol Cancer"},{"key":"2659_CR4","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1245\/s10434-014-3864-6","volume":"21","author":"S Bendifallah","year":"2014","unstructured":"Bendifallah S, Canlorbe G, Huguet F, Coutant C, Hudry D, Graesslin O et al (2014) A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre study. Ann Surg Oncol 21:4239\u20134245","journal-title":"Ann Surg Oncol"},{"key":"2659_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","volume":"373","author":"P Blake","year":"2009","unstructured":"Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H et al (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 373:137\u2013146","journal-title":"Lancet"},{"key":"2659_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1006\/gyno.1999.5526","volume":"75","author":"M Chadha","year":"1999","unstructured":"Chadha M, Nanavati PJ, Liu P, Fanning J, Jacobs A (1999) Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 75:103\u2013107","journal-title":"Gynecol Oncol"},{"key":"2659_CR7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S1470-2045(07)70275-9","volume":"8","author":"JK Chan","year":"2007","unstructured":"Chan JK, Kapp DS (2007) Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol 8:831\u2013841","journal-title":"Lancet Oncol"},{"issue":"Suppl 6","key":"2659_CR8","first-page":"vi35vi39","volume":"22","author":"N Colombo","year":"2011","unstructured":"Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C et al (2011) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22(Suppl 6):vi35\u2013vi39","journal-title":"Ann Oncol"},{"key":"2659_CR9","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/annonc\/mdv484","volume":"27","author":"N Colombo","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J et al (2016) ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol 27:16\u201341","journal-title":"Ann Oncol"},{"key":"2659_CR10","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355:1404\u20131411","journal-title":"Lancet"},{"key":"2659_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ygyno.2004.05.009","volume":"94","author":"B DuBeshter","year":"2004","unstructured":"DuBeshter B, Estler K, Altobelli K, McDonald S, Glantz C, Angel C (2004) High-dose rate brachytherapy for Stage I\/II papillary serous or clear cell endometrial cancer. Gynecol Oncol 94:383\u2013386","journal-title":"Gynecol Oncol"},{"key":"2659_CR12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00432-015-2109-9","volume":"142","author":"H Eggemann","year":"2016","unstructured":"Eggemann H, Ignatov T, Kaiser K, Burger E, Costa SD, Ignatov A (2016) Survival advantage of lymphadenectomy in endometrial cancer. J Cancer Res Clin Oncol 142:1051\u20131060","journal-title":"J Cancer Res Clin Oncol"},{"key":"2659_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijrobp.2013.11.003","volume":"88","author":"MA Elshaikh","year":"2014","unstructured":"Elshaikh MA, Vance S, Suri JS, Mahan M, Munkarah A (2014) Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma. Int J Radiat Oncol Biol Phys 88:351\u2013356","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2659_CR14","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","volume":"46","author":"T Hogberg","year":"2010","unstructured":"Hogberg T, Signorelli M, de Oliveira CF, Fossati R, Lissoni AA, Sorbe B et al (2010) Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2014results from two randomised studies. Eur J Cancer 46:2422\u20132431","journal-title":"Eur J Cancer"},{"key":"2659_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","volume":"92","author":"HM Keys","year":"2004","unstructured":"Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:744\u2013751","journal-title":"Gynecol Oncol"},{"key":"2659_CR16","first-page":"e639e644","volume":"81","author":"A Kim","year":"2011","unstructured":"Kim A, Schreiber D, Rineer J, Choi K, Rotman M (2011) Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma. Int J Radiat Oncol Biol Phys 81:e639\u2013e644","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2659_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(09)60678-4","volume":"373","author":"H Kitchener","year":"2009","unstructured":"Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125\u2013136","journal-title":"Lancet"},{"key":"2659_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ygyno.2006.05.002","volume":"103","author":"OK Macdonald","year":"2006","unstructured":"Macdonald OK, Sause WT, Lee RJ, Lee CM, Dodson MK, Zempolich K et al (2006) Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women. Gynecol Oncol 103:661\u2013666","journal-title":"Gynecol Oncol"},{"key":"2659_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","volume":"95","author":"R Maggi","year":"2006","unstructured":"Maggi R, Lissoni A, Spina F, Melpignano M, Zola P, Favalli G et al (2006) Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 95:266\u2013271","journal-title":"Br J Cancer"},{"key":"2659_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ygyno.2009.06.027","volume":"116","author":"SA McCloskey","year":"2010","unstructured":"McCloskey SA, Tchabo NE, Malhotra HK, Odunsi K, Rodabaugh K, Singhal P et al (2010) Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecol Oncol 116:404\u2013407","journal-title":"Gynecol Oncol"},{"key":"2659_CR21","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","volume":"27","author":"RA Nout","year":"2009","unstructured":"Nout RA, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM et al (2009) Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol 27:3547\u20133556","journal-title":"J Clin Oncol"},{"key":"2659_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","volume":"375","author":"RA Nout","year":"2010","unstructured":"Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375:816\u2013823","journal-title":"Lancet"},{"key":"2659_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103\u2013104","journal-title":"Int J Gynaecol Obstet"},{"key":"2659_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","volume":"24","author":"ME Randall","year":"2006","unstructured":"Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J et al (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24:36\u201344","journal-title":"J Clin Oncol"},{"key":"2659_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/IGC.0b013e3181a6c9df","volume":"19","author":"B Sorbe","year":"2009","unstructured":"Sorbe B, Nordstrom B, Maenpaa J, Kuhelj J, Kuhelj D, Okkan S et al (2009) Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study. Int J Gynecol Cancer 19:873\u2013878","journal-title":"Int J Gynecol Cancer"},{"key":"2659_CR26","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","volume":"82","author":"B Sorbe","year":"2012","unstructured":"Sorbe B, Horvath G, Andersson H, Boman K, Lundgren C, Pettersson B (2012) External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma\u2014a prospective randomized study. Int J Radiat Oncol Biol Phys 82:1249\u20131255","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2659_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","volume":"108","author":"N Susumu","year":"2008","unstructured":"Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S et al (2008) Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 108:226\u2013233","journal-title":"Gynecol Oncol"},{"key":"2659_CR28","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Elm von","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457","journal-title":"Lancet"},{"key":"2659_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/gyno.1998.5155","volume":"71","author":"E Weiss","year":"1998","unstructured":"Weiss E, Hirnle P, Arnold-Bofinger H, Hess CF, Bamberg M (1998) Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy. Gynecol Oncol 71:72\u201376","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-018-2659-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-2659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-2659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T10:31:31Z","timestamp":1557138691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-018-2659-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,5]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["2659"],"URL":"https:\/\/doi.org\/10.1007\/s00432-018-2659-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2018,5,5]]},"assertion":[{"value":"10 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients before treatment. According to the statement of Research and Ethical Committee, Otto-von-Guericke University, Magdeburg, Germany, an additional individual consent was not required for this analysis. Before analysis, patient data underwent a pesudonymisation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}